Article
Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1alpha.
Molecular cancer - 11 Oct 2007
Lu Yang, Liang Ke, Li Xinqun, Fan Zhen
Abstract excerpt
BACKGROUND: Searching for novel molecular markers that dependably predict or indicate responses of human cancer cells to epidermal growth factor receptor (EGFR)-targeted therapy is strongly warranted. The purpose of the current study was to evaluate hypoxia-inducible factor-1alpha (HIF-1alpha) as a novel response marker compared with previously explored markers following treatment with an EGFR-blocking monoclonal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.